Medex
Coumadin - anticoagulant of indirect action. It is taken for treatment and prevention of a deep vein thrombosis and embolism of a pulmonary artery, the transitory ischaemic attacks and an ischemic stroke, secondary prevention of myocardial infarction and prevention of tromboembolic episodes after a myocardial infarction, prevention of tromboembolic episodes at patients with fibrillation of auricles, cardiac valve damage or with the fitted prosthesis heart valves.
Principio attivo: coumadin
Disponibilità: In Stock (60 packages)
Spedizione standard con posta aerea gratuita per ordini inferiori a £154.40
Medex, 5mg
| Pacchetto | Per confezione | Ordine | |
|---|---|---|---|
| 60 pills x 5mg | £0.72 | £43.36 | |
| 90 pills x 5mg | £0.61 |
|
|
| 120 pills x 5mg | £0.55 |
|
|
| 180 pills x 5mg | £0.50 |
|
|
| 270 pills x 5mg | £0.46 |
|
|
360 pills x 5mg
Free airmail shipping |
£0.44 |
|
Medex, 1mg
| Pacchetto | Per confezione | Ordine | |
|---|---|---|---|
| 90 pills x 1mg | £0.42 | £37.41 | |
| 180 pills x 1mg | £0.33 |
|
|
| 270 pills x 1mg | £0.30 |
|
|
| 360 pills x 1mg | £0.29 |
|
Descrizione del prodotto
Confezione
Medex (Coumadin)
Coumadin Product Description
Drug Uses
Oral anticoagulant Coumadin is indicated to treat or prevent re-formation of blood clots in the coronary, peripheral and cerebral arteries. Also, Coumadin can be used for prophylaxis of blood thickening after cardiovascular (heart) surgery and implanted artificial heart valve.
Anticoagulant therapy with Coumadin can be initiated if the patient was diagnosed with:
Intracranial aneurysms;
Different types of embolism;
Damage to the heart tissue;
Inflammation of blood vessels;
Partial loss of heart function associated with thromboembolic events.
The standard anticoagulant therapy involves the minimum daily dose of Coumadin (from 2 to 5 mg) once a day. To improve and maintain an anticoagulant effect, the dose of Coumadin can be increased to 10 mg per day.
Missed Dose
If a patient is taking Coumadin tablets in the morning or in the afternoon, the missed dose can be taken throughout the day. Two or more recommended doses of Coumadin should not be taken on the same day. If you have missed one or more doses of Coumadin, the next daily dose of the oral anticoagulant should be taken as scheduled.
More Information
A significant anticoagulant effect is achieved in about four days after the start of Coumadin application. Once the course of thrombosis treatment or prophylaxis is completed, Coumadin tablets continue to work for several days.
Storage
Anticoagulant Coumadin should be protected from bright light and humidity, and stored in a tightly closed container at room temperature up to 30°C.
Coumadin Safety Information
Warnings
Before to start the application of anticoagulant agent Coumadin, a patient should learn measures to reduce the risks of internal and external bleeding. In case of the long-term anticoagulant therapy for over 1 year, Coumadin dose schedule may require to be adjusted.
Disclaimer
All the information about cardiovascular diseases, provided in the review of Coumadin is developed for information purposes only. This review about Coumadin is not intended to substitute for the medical advice of phlebologists or cardiologists. The online pharmacy shall not be liable for damage, which may be caused by the provided information about thromboembolic events and Coumadin.
Coumadin Side Effects
Coumadin provides an anticoagulant effect, so hemorrhage is the main side effect of this drug. Clinical studies of the drug have demonstrated that Coumadin-related hemorrhage may result in: hematemesis, contusion, hematochezia, hemoptysis, menorrhagia, hematuria, petechia and intracranial hemorrhage. Other side effects that may be caused by Coumadin are: mialgia, headache, swelling, paralysis, dizziness, weakness, shock, abdomen pain, hypotension, breath disorders and paraesthesia.
Packaging info
This is how your parcel will look like, the images are photographs of real shipments.
It has the size of a normal protected envelope and it does not disclose its contents.
